FDA Approved: ATOMOXETINE — Supplemental Application (Northstar Rx LLC)

View source ↗

Summary

FDA approves a supplemental application for atomoxetine from Northstar Rx LLC under ANDA 079019, enabling a generic version of the ADHD medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

SUPPL AP for ATOMOXETINE (ATOMOXETINE)